Price $135.24 |
Market Cap
4.19B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
72.2
|
P/B
5.47
|
P/S
4.18
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
74.3
|
Op. Cash Flow
98.1K
|
FCF
1.9
|
|
Op. Margin
9.80%
|
Net Margin
6.30%
|
ROE
8.50%
|
ROI
3.70%
|
|
ROA
3.50%
|
EPS Growth
-
|
Current Ratio
2.2
|
Debt/Equity
103.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $27.08 | - | - | 9.86B | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.78 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $64.93 | - | 3.50% | 138.77B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $22.63 | - | - | 1.09B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.21 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
